The cell-type-specificity of inherited predispositions to tumours: Review and hypothesis

Cancer Letters

Volumn 216, Issue 2, 2004, Pages 127-146

  Bignold, Leon P ^a  

^a INSTITUTE OF MEDICAL AND VETERINARY SCIENCE   (Australia)

Author keywords

Co mutation; Genes; Inherited predispositions; Micrornas; Replicative fidelity of DNA; Tumours

Indexed keywords

APC PROTEIN; DNA POLYMERASE; GENE PRODUCT; MICRORNA; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN RET; TRANSCRIPTION FACTOR;

ALLELE; ANGIOLIPOMA; AUTOSOMAL RECESSIVE DISORDER; CANCER SUSCEPTIBILITY; CELL DIFFERENTIATION; CELL SPECIFICITY; CELL TYPE; CYTOGENETICS; DNA FLANKING REGION; DNA MODIFICATION; DNA REPLICATION; EXON; FLUORESCENCE IN SITU HYBRIDIZATION; GARDNER SYNDROME; GENE EXPRESSION; GENE LOCATION; GENE MUTATION; GENETIC LINKAGE; GENETIC STABILITY; GERM LINE; HUMAN; INHERITANCE; INTRON; PLEIOTROPY; PRIORITY JOURNAL; RETINOBLASTOMA; SHORT SURVEY; STATISTICAL SIGNIFICANCE; TUMOR SUPPRESSOR GENE; TURCOT SYNDROME;

EID: 7744226278     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2004.07.037     Document Type: Review

References (163)

1. N.R. Schneider, W.R. Williams, and R.S. Chaganti Genetic epidemiology of familial aggregation of cancer Adv. Cancer Res. 47 1986 1 36
2. J. Cohnheim Lectures in General Pathology (Translated A.B. McKee) 1882 New Sydenham Society London
3. J. Wolff The Science of Cancerous Diseases from the Earliest Times to the Present. Originally published in German (Translated S. Jarcho) 1990 Science History Publishers Sagamore Beach, MA
4. T.H. Morgan Some Possible Bearings of Genetics on Pathology 1922 New Era Printing Co Lancaster, PA
5. C.H. Little The relation of genetics to the problems of cancer reserch Harvey Lectures 17 1922-1923 65 88
6. K.H. Bauer Mutationstheorie der Geschwulst-Entstehung The Mutation Theory in Tumour formation 1928 Julius Springer Berlin
7. P.J. Lockhart-Mummery The Origin of Cancer 1934 JA Churchill London p. 68
8. H.J. Muller Radiation Damage to the Genetic Material Science in Progress, 9th series 1951 Yale University Press New Haven pp. 93-165, see also pp. 481-493
9. C.E. Nordling A new theory of the cancer-inducing mechanism Br. J. Cancer 7 1953 68 72
10. J.C. Fisher Multiple-mutation theory of carcinogenesis Nature 181 1958 651 652
11. P.R.J. Burch A biologic principle and its converse: some implications for carcinogenesis Nature 195 1962 241 243
12. P.R.J. Burch Carcinogenesis and cancer prevention Nature 197 1963 1145 1151
13. D.J.B. Ashley The two hit and multiple hit theories of carcinogenesis Br. J. Cancer 23 1969 313 328
14. D.E. Comings A general theory of carcinogenesis Proc. Natl Acad. Sci. USA 70 1973 3324 3328
15. A.G. Knudson Mutation and cancer: statistical study of retinoblastoma Proc. Natl Acad. Sci. 68 1971 820 823
16. A.G. Knudson Mutation and human cancer Adv. Cancer Res. 17 1973 317 352
17. B. Vogelstein, and K.W. Kinzler The multistep nature of cancer Trends Genet. 9 1993 138 141
18. S.H. Moolgavkar, and E.G. Luececk Multistage carcinogenesis and the incidence of human cancers Genes Chromosomes Cancer 38 2003 302 306
19. R.J. Huebner, and G.J. Todaro Oncogenes of RNA tumor viruses as determinants of cancer Proc. Natl Acad. Sci. USA 64 1969 1087 1094
20. H.E. Varmus Viruses, genes, and cancer. I. The discovery of cellular oncogenes and their role in neoplasia Cancer 55 1985 2324 2328
21. J.M. Bishop Nobel Lecture. Retroviruses and oncogenes II Biosci. Rep. 10 1990 473 491
22. J.M. Bishop Molecular themes in oncogenesis Cell 64 1991 235 248
23. H.T. Lynch, and A.J. Krush Cancer family G revisited: 1895-1970 Cancer 27 1971 1505 1511
24. A.S. Warthin Heredity with reference to carcinoma Arch. Int. Med. 12 1913 546 555
25. A.G. Knudson Genetics of human cancer Genetics 79 Suppl 1975 305 316
26. T.A. Seemayer, and W.K. Cavenee Molecular mechanisms of oncogenesis Lab. Invest. 60 1989 585 599
27. A.G. Knudson Hereditary cancer, oncogenes and anti-oncogenes Cancer Res. 45 1985 1437 1443
28. J.M. Adams, and S. Cory Transgenic models of tumor development Science 254 1991 1161 1167
29. H. Harris, O.J. Miller, G. Klein, P. Worst, and T. Tachibana Suppression of malignancy by cell fusion Nature 223 1969 363 368
30. B. Ephrussi, R.L. Davidson, M.C. Weiss, H. Harris, and G. Klein Malignancy of somatic cell hybrids Nature 224 1969 1314 1316
31. S. Imreh, G. Klein, and E.R. Zabarovsky Search for unknown tumor-antagonizing genes Genes Chromosomes Cancer 38 2003 307 321
32. A.G. Knudson, L.C. Strong, and D.E. Anderson Heredity and cancer in man Prog. Med. Genet. 9 1973 113 158
33. A.G. Knudson Genetics and the etiology of human cancer Adv. Hum. Genet. 8 1977 1 66
34. A.G. Knudson Genetics of human cancer J. Cell Physiol. Suppl. 4 1986 7 11
35. A.G. Knudson Genetics of human cancer Annu. Rev. Genet. 20 1986 231 251
36. A.G. Knudson Hereditary cancers: clues to mechanisms of carcinogenesis Br. J. Cancer 59 1989 661 666
37. A.G. Knudson Epidemiology of genetically determined cancer Ciba Found. Symp. 142 1989 3 12
38. A.G. Knudson Stem cell regulation, tissue ontogeny and oncogenic events Cancer Biol. 3 1992 99 106
39. A.G. Knudson Anti-oncogenes and human cancer Proc. Natl Acad. Sci. 90 1993 10914 10921
40. A.G. Knudson Mutation and cancer, a personal odyssey Adv. Cancer Res. 67 1995 1 23
41. A.G. Knudson Hereditary predisposition to cancer Ann. NY Acad. Sci. 833 1997 58 67
42. A.G. Knudson Chasing the cancer demon Annu. Rev. Genet. 34 2000 1 19
43. A.G. Knudson Two hits (more or less) to cancer Nat. Rev. Genet. 2 2001 157 162
44. A.G. Knudson Cancer genetics Am. J. Med. Genet. 111 2002 96 102
45. A.G. Knudson Cancer genetics through a personal retrospectoscope Genes Chromosomes Cancer 38 2003 288 291
46. W.K. Cavenee, T.P. Dryja, R.A. Phillips, W.F. Benedict, R. Godbout, B.L. Gallie, A.L. Murphree, L.C. Strong, and R.L. White Expression of recessive alleles by chromosomal mechanisms in retinoblastoma Nature 305 1983 779 784
47. W.K. Cavenee, M.F. Hansen, H.J. Scrable, and C.D. James Loss of genetic information in cancer Ciba Found. Symp. 142 1989 79 88 discussion 88-92
48. M. Nordenskjold, and C. Lundberg Recessive cancer genes and chromosomal mechanisms in tumorigenesis Ann. Clin. Res. 18 1986 307 313
49. G.R. Skuse, and P.T. Rowley Tumor suppressor genes and inherited predisposition to malignancy Semin. Oncol. 16 1989 128 137
50. B.R. Seizinger, and X.O. Breakefield The role of 'tumor suppressor' genes in neural tumors Trends Neurosci. 13 1990 3 6
51. R.A. Weinberg Tumour suppressor genes Science 254 1991 1138 1146
52. A.J. Levine The tumour suppressor genes Annu. Rev. Biochem. 62 1993 623 651
53. A.J. Levine, M.C. Wu, A. Chang, A. Silver, A.F. Attiyeh, J. Lin, and C.B. Epstein The spectrum of mutations at the p53 locus Ann. NY Acad. Sci. 768 1995 111 128
54. C.C. Harris The 1995 Walter Hubert Lecture-molecular epidemiology of human cancer: insights from the mutational analysis of the p53 tumour-suppressor gene Br. J. Cancer. 73 1996 261 269
55. M.L. Hooper Tumour suppressor gene mutations in humans and mice: parallels and contrasts Eur. Med. Biol. Org. J. 17 1998 6783 6789
56. P. Guildford The inherited susceptibility to cancer Cell. Mol. Life Sci. 57 2000 589 603
57. D.J. Marsh, and R.T. Zori Genetic insights into familial cancers - update and recent discoveries Cancer Lett. 181 2002 125 164
58. A.J. Paige Redefining tumour suppressor genes: exceptions to the two-hit hypothesis Cell. Mol. Life Sci. 60 2003 2147 2163
59. E.M. Nicholls Somatic variation and multiple neurofibromatosis Hum. Hered. 19 1969 473 479
60. D.B. Levy, K.J. Smith, Y. Beazer-Barclay, S.R. Hamilton, B. Vogelstein, and K.W. Kinzler Inactivation of both APC alleles in human and mouse tumors Cancer Res. 54 1994 5953 5958
61. J.R. Wagner, and W.M. Linehan Molecular genetics of renal cell carcinoma Semin. Urol. Oncol. 14 1996 244 249
62. A.C. Santos, M.G. Boavida, A. Costa, and L. Osorio-Almeida Identification of a new WT1 mutation in a sporadic Wilms' tumour Biochim. Biophys. Acta 1407 1988 109 113
63. S.J. Baker, K.W. Kinzler, and B. Vogelstein Knudson's hypothesis and the TP53 revolution Genes Chromosomes Cancer 38 2003 329
64. O. Hino Hereditary renal carcinogenesis fitting Knudson's two-hit model: genotype, environment, and phenotype Genes Chromosomes Cancer 38 2003 357 367
65. S. Venkatachalam, and L.A. Donehower Murine tumor suppressor models Mutation Res. 400 1998 391 407
66. A.S. Yee, H.H. Shih, and S.G. Tevosian New perspectives on retinoblastoma functions in differentiation Front. Biosci. 3 1998 d532 d547
67. K.Y. Tsai, D. MacPherson, D.A. Rubinson, A.Y. Nikitin, R. Bronson, and K.L. Mercer ARF mutation accelerates pituitary tumor development in Rb+/- mice Proc. Natl Acad. Sci. USA 99 2002 16865 16870
68. T.P. Dryja, S. Friend, and R.A. Weinberg Genetic sequences that predispose to retinoblastoma and osteosarcoma Symp. Fundam. Cancer Res. 39 1986 115 119
69. D.W. Goodrich, and W-H. Lee The molecular genetics of retinoblastoma Cancer Surv. 9 1990 529 554
70. M.E. Ewen The cell cycle and the retinoblastoma protein family Cancer Metastasis Rev. 13 1994 45 66
71. M.M. Lipinski, and T. Jacks The retinoblastoma gene family in differentiation and development Oncogene 18 1999 7873 7882
72. C. Eng RET proto-oncogene in the development of human cancer J. Clin. Oncol. 17 1999 380 393
73. F.D. Kitchin, and R.M. Ellsworth Pleiotropic effects of the gene for retinoblastoma J. Med. Genet. 11 1974 244 246
74. M.F. Hansen, A. Koufos, B.L. Gallie, R.A. Phillips, O. Fodstad, and A. Brogger Osteosarcoma and retinoblastoma: a shared chromosomal mechanism revealing recessive predisposition Proc. Natl Acad. Sci. USA 82 1985 6216 6220
75. J.M. Horowitz Regulation of transcription by the retinoblastoma protein Genes Chromosomes Cancer 6 1993 124 131
76. C. Englert WT - more than a transcription factor? Trends Biochem. Sci. 23 1998 389 393
77. A.A. Pannett, and R.V. Thakker Somatic mutations in MEN type 1 tumours, consistent with the Knudson two-hit hypothesis J. Endocrinol. Metab. 86 2001 4371 4474
78. J.R. Nevins The Rb/E2F pathway and cancer Hum. Mol. Genet. 10 2001 699 703
79. S.B. Lee, and D.A. Haber Wilms tumor and the WT1 gene Exp. Cell Res. 264 2001 74 99
80. D.W. Nebert Transcription factors and cancer: an overview Toxicology 181-182 2002 131 141
81. G. Wahl, and O. Vafa Genetic instability, oncogenes, and the p53 pathway Cold Spring Harb. Symp. Quant. Biol. 65 2000 511 5520
82. L. Zheng, and W-H. Lee Retinoblastoma tumor suppressor and genome stability Adv. Cancer Res. 85 2002 13 50
83. R. Scully Role of BRCA gene dysfunction in breast and ovarian cancer predisposition Breast Cancer Res. 2 2000 324 330
84. R. Scully, and D.M. Livingston In search of the tumour-suppressor functions of BRCA1 and BRCA 2 Nature 408 2000 429 432
85. T.H. Morgan, A.H. Sturtevant, H.J. Muller, and C.B. Bridges The Mechanism of Mendelian heredity 1915 Constable London
86. R.A. Weinberg (Discussion) Ciba Found. Symp. 142 1989 13
87. C. Eng, and B.A. Ponder The role of gene mutations in the genesis of familial cancers Fed. Am. Soc. Exp. Biol. J. 7 1993 910 919
88. E.R. Fearon Human cancer syndromes: clues ot the origin and nature of cancer Science 278 1997 1043 1050
89. R. White Inherited cancer genes Curr. Opin. Genet. Dev. 2 1992 53 57
90. P. Fei, E.J. Bernhard, and W.S. El-Deiry Tissue-specific patterns of p53 - inducible genes (p53 targets) Cancer Res. 62 2002 7316 7327
91. K.L. Nathanson, and B.L. Weber Other breast cancer susceptibility genes: searching for more holy grail Hum. Mol. Genet. 10 2001 715 720
92. M.A. Brown, and A.E. Solomon Studies on inherited cancers: outcomes and challenges of 25 years Trends Genet. 13 1997 202 206
93. R. Hakem, and T.W. Mak Animal models of tumour-suppressor genes Annu. Rev. Genet. 35 2001 209 241
94. T.A. Dragani 10 years of mouse cancer modifier loci: human relevance Cancer Res. 63 2003 3011 3018
95. M. Dean Approaches to identify genes for complex human disorders: lessons from Mendelian disorders Hum. Mutat. 22 2003 261 274
96. S. Cory, and J.M. Adams Transgenic mice and oncogenesis Annu. Rev. Immunol. 6 1988 25 48
97. E. Gilbert, A. Morel, M. Tulliez, R. Maunoury, F. Terzi, L. Miquerol, and A. Kahn In vivo effects of activated H-ras oncogene expressed in the liver and in urogenital tissues Int. J. Cancer 73 1997 749 756
98. R. Godbout, T.P. Dryja, J. Squire, B.L. Gallie, and R.A. Phillips Somatic inactivation of genes on chromosome 13 is a common event in retinoblastoma Nature 304 1983 451 453
99. B. Alberts A. Johnson J. Lewis M. Raff K. Roberts P. Walter Molecular Biology of the Cell 4th ed 2002 Garland Science New York
100. T. Strachan, and A.P. Read Human Molecular Genetics 1999 Wiley New York
101. D.P. Wolfer, W.E. Crusio, and H.P. Lipp Knockout mice: simple solutions to the problems of genetic background and flanking genes Trends Neurosci. 25 2002 336 340
102. U. Fiedler, W. Ehlers, A. Meye, S. Fussel, G. Faller, U. Schmidt, and M.P. Wirth LOH analyses in the region of the putative tumour suppressor gene C13 on chromosome 13q13 Anticancer Res. 21 2001 2341 2350
103. A. Baldi, V. Boccia, P.P. Claudio, A. De Luca, and A. Giordano Genomic structure of the human retinoblastoma-related Rb2/p130 gene Proc. Natl Acad. Sci. USA 93 1996 4629 4632
104. K. Huebner, P.C. Nowell, and C.M. Croce Lineage-specific gene rearrangement/deletion: a nonconservative model Cancer Res. 49 1989 4071 4074
105. R.A. Weinberg The molecular basis of retinoblastoma Ciba Found. Symp. 142 1989 99 105
106. P.A. Hamel, R.A. Phillips, M. Muncaster, and B.L. Gallie Speculations on the roles of RB1 in tissue specific differentiation, tumour initiation and tumour progression Fed. Am. Soc. Eur. Biol. J. 7 1993 846 854
107. A.R. Venkitaraman Cancer susceptibility and the functions of BRCA1 and BRCA2 Cell 108 2002 171 182
108. T. Tucker, and J.M. Friedman Pathogenesis of hereditary tumors: beyond the two-hit hypothesis Clin. Genet. 62 2002 345 357
109. C.D. Roskelly, and M.J. Bissell The dominance of the microenvironment in breast and ovarian cancer Semin. Cancer Biol. 12 2002 97 104
110. A.N. Montiero BRCA1: the enigma of tissue-specific tumor development Trends Genet. 19 2003 312 315
111. D. Kaufmann, W. Leistner, P. Kruse, O. Kenner, S. Hoffmeyer, and C. Hein Aberrant splicing in several human tumors in the tumor suppressor genes neurofibromatosis type 1, neurofibromatosis type 2, and tuberous sclerosis 2 Cancer Res. 62 2002 1503 1509
112. V.R. Potluri, L. Helson, R.M. Ellsworth, T. Reid, and F. Gilbert Chromosomal abnormalities in human retinoblastoma. A review Cancer 58 1986 663 671
113. J. Squire, R.A. Phillips, S. Boyce, R. Godbout, B. Rogers, and B.L. Gallie Isochromosome 6p, a unique chromosomal abnormality in retinoblastoma: verification by standard staining techniques, new densitometric methods, and somatic cell hybridization Hum. Genet. 66 1984 46 53
114. K.P.S. Amare, P. Ghule, J. Jose, M. Bamne, P. Kurkure, and S. Banavali Constitutional genomic instability, chromosome aberrations in tumor cells and retinoblastoma Cancer Genet. Cytogenet. 150 2004 33 43
115. J. Marx Debate surges over the origins of genomic defects in cancer Science 297 2003 544 556
116. L.P. Bignold Initiation of genetic instability and tumour formation: a review and hypothesis of a nongenotoxic mechanism Cell. Mol. Life Sci. 60 2003 1107 1117
117. L.P. Bignold Carcinogen-induced impairment of enzymes for replicative fidelity of DNA and the initiation of tumours Carcinogenesis 25 2004 299 307
118. C. Dennis The brave new world of RNA Nature 418 2002 122 124
119. J.S. Mattick Challenging the dogma: the hidden layer of non-protein-coding RNAs in complex organisms Bioessays 25 2003 930 939
120. E.G. Moss MicroRNAs: hidden in the genome Curr. Biol. 12 2002 R138 R140
121. A.E. Pasquinelli, and G. Ruvkun Control of developmental timing by microRNAs and their targets Annu. Rev. Cell Dev. Biol. 18 2002 495 513
122. G. Ruvkun Glimpses of a tiny RNA world Science 294 2001 797 799
123. J.S. Mattick, Non-coding RNAs: the architects of eukaryotic complexity, EMBO Reports 21 (2001) 986-991.
124. N.R. Wall, and Y. Chi Small RNA: can RNA interference be exploited for therapy? Lancet 362 2003 1401 1403
125. A. Herbert The four Rs of RNA-directed evolution Nat. Genet. 36 2004 19 25
126. C.P. Bartel, and C.Z. Chen Micromanagers of gene expression: the potentially widespread influence of metazoan microRNAs Nat. Rev. Genet. 5 2004 396 400
127. M.T. McManus MicroRNAs and cancer Semin. Cancer Biol. 13 2003 253 258
128. S.S. Guo, and M.P. Sawicki Molecular and genetic mechanisms of tumorigenesis in multiple endocrine neoplasia type-1 Mol. Endocrinol. 15 2001 1653 1664
129. D.H. Schussheim, M.C. Skarulis, S.K. Agarwal, W.F. Simonds, A.L. Burns, A.M. Spiegel, and S.J. Marx Multiple endocrine neoplasia type 1: new clinical and basic findings Trends Endocrinol. Metab. 12 2001 173 178
130. R.V. Thakker Multiple endocrine neoplasia type 1 Endocrinol. Metab. Clin. North Am. 29 2000 541 567
131. F. Gibril, M. Schumann, A. Pace, and R.T. Jensen Multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome: a prospective study of 107 cases and comparison with 1009 cases from the literature Medicine (Baltimore) 83 2004 43 83
132. T.M. Lynch, and D.H. Gutmann Neurofibromatosis 1 Neurol. Clin. 20 2002 841 865
133. K. Stevens Genetics of neurofibromatosis 1-associated peripheral nerve sheath tumors Cancer Invest. 21 2003 897 914
134. D.H. Gutmann The neurofibromatoses: when less is more Hum. Mol. Genet. 10 2001 747 755
135. G.H. Xiao, J. Chernoff, and J.R. Testa NF2: the wizardry of merlin Genes Chromosomes Cancer 38 2003 389 399
136. M.E. Moynahan The cancer connection: BRCA1 and BRCA2 tumor suppression in mice and humans Oncogene 21 2003 8994 9007
137. S.R. Hamilton, B. Liu, R.E. Parsons, N. Papadopoulos, J. Jen, S.M. Powell, A.J. Krush, T. Berk, Z. Cohen, and B. Tetu The molecular basis of Turcot's syndrome New Engl. J. Med. 332 1995 839 847
138. L.I. Yoo, D.C. Chung, and J. Yuan LKB1 - a master tumour suppressor of the small intestine and beyond Nat. Rev. Cancer 2 2002 529 535
139. Y. Niida, A.O. Stemmer-Rachamimov, M. Logrip, D. Tapon, R. Perez, and D.J. Kwiatkowski Survey of somatic mutations in tuberous sclerosis complex (TSC) hamartomas suggests different genetic mechanisms for pathogenesis of TSC lesions Am. J. Hum. Genet. 69 2001 493 503
140. G.J. Draper, B.M. Sanders, and J.E. Kingston Second primary neoplasms in patients with retinoblastoma Br. J. Cancer 53 1986 671
141. C. Mitchell Second malignant neoplasms in retinoblastoma. Fact and fiction Ophthalmic Paediatr. Genet. 9 1988 161 165
142. D.C. Chung, and A.K. Rustgi The hereditary nonpolyposis colorectal cancer syndrome: genetics and clinical implications Ann. Intern. Med. 138 2003 560 570
143. R.J. Gorlin Nevoid basal cell carcinoma (Gorlin) syndrome: unanswered issues J. Lab. Clin. Med. 134 1999 551 552
144. M.R. Gailani, and A.E. Bale Developmental genes and cancer: role of patched in basal cell carcinoma of the skin J. Natl Cancer Inst. 89 1977 1103 1109
145. R. Fodde The APC gene in colorectal cancer Eur J Cancer 38 2002 867 871
146. W.D. Foulkes A tale of four syndromes: familial adenomatous polyposis. Gardner syndrome, attenuated APC and Turcot syndrome Q. J. Med. 88 1995 853 863
147. K.H. Goss, and J. Groden Biology of the adenomatous polyposis coli tumor suppressor J. Clin. Oncol. 18 2000 1967 1979
148. B.M. Wehrli, S.W. Weiss, and C.M. Coffin Gardner syndrome Am. J. Surg. Pathol. 25 2001 694 696
149. M. De Rosa, C. Fasano, L. Panariello, M.I. Scarano, G. Belli, and A. Iannelli Evidence for a recessive inheritance of Turcot's syndrome caused by compound heterozygous mutations within the PMS2 gene Oncogene 19 2000 1719 1723
150. R.R. Lonser, G.M. Glenn, M. Walther, E.Y. Chew, S.K. Libutti, W.M. Linehan, and E.H. Oldfield Von Hippel-Lindau disease Lancet 361 2003 2059 2067
151. C. Eng The RET proto-oncogene in multiple endocrine neoplasia type 2 and Hirschsprung's disease New Engl. J. Med. 335 1996 943 951
152. C. Eng, and L.M. Mulligan Mutations of the RET proto-oncogene in the multiple endocrine neoplasia type 2 syndromes, related sporadic tumours, and hirschsprung disease Hum. Mutat. 9 1997 97 109
153. S.M. Jhiang The RET proto-oncogene in human cancers Oncogene 19 2000 5590 5597
154. C. Eng PTEN: one gene, many syndromes Hum. Mutat. 22 2003 183 198
155. P.K. Geyer, and I. Clark Protecting against promiscuity: the regulatory role of insulators Cell. Mol. Life Sci. 59 2002 2112 2127
156. E.J. Kuhn, and P.K. Geyer Genomic insulators: connecting properties to mechanism Curr. Opin. Cell Biol. 15 2003 259 265
157. J.E. Cleaver Hair today, gone tomorrow: transgenic mice with human repair deficient hair disease Cell 93 1998 1099 1102
158. R.R. Laposa, and J.E. Cleaver DNA repair on the brain Proc. Natl Acad. Sci. USA 98 2001 12860 12862
159. R.E. Moses DNA damage processing defects and disease Annu. Rev. Genomics Hum. Genet. 2 2001 41 68
160. A.G. Knudson Jr., A.T. Meadows, W.W. Nichols, and R. Hill Chromosomal deletion and retinoblastoma N. Engl. J. Med. 295 1976 1120 1123
161. P.P. Rosen, and H.A. Oberman Tumours of the mammary gland (Atlas of Tumour Pathology, Ser 3, Fascilce 7) 1993 Armed Forces Institute of Pathology Washington, DC
162. M. Mühlmann Molecular cytogenetics in metaphase and interphase cells for cancer and genetic research, diagnosis and prognosis. Application in tissue sections and cell suspensions Genet. Mol. Res. 1 2002 117 127
163. J. Damjanovich, R. Adany, A. Berta, Z. Beck, and M. Balazs Mutation of the RB1 gene caused unilateral retinoblastoma in early age Cancer Genet. Cytogenet. 119 2000 1 7